Sixty ICR male mice were used to establish H<sub>22</sub> mice models of liver cancer and then randomly divided into six groups, the normal control group, the model control group, the positive group (cyclophosphamide [CTX]), the BFAT-treated group (high, 4 g/kg, medium, 2 g/kg, and low, 1 g/kg).
Hundred and twenty ICR male mice were used to establish three models of a solid tumor H<sub>22</sub> liver cancer, ascites tumor, and immunodeficiency in male mice and models group of a solid tumor H<sub>22</sub> liver cancer randomly divided into six groupshe normal control group, the model control group, the positive group (cyclophosphamide), the sample treated group (high - 1.300 g/kg, medium - 0.750 g/kg, low - 0.373 g/kg).